Interestingly, we observed an enrichment of E2F and MYC targets in poorly differentiated tumor foci compared to adenocarcinoma, suggesting that E2F and N-Myc may have altered or enhanced activity in the transition from adenocarcinoma to a poorly differentiated state. This evidence concerns the gene MYC and adenocarcinoma.